Lana Elia
Family · Commerce Township, MINPI 1619487550
Payments from drug & device makers
Across 74 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$324
- AbbVie$240
- AstraZeneca$155
- Lilly USA, LLC$104
- Biohaven Pharmaceuticals, Inc.$98
- GSK$84
- plus $439 from 13 others
What the payments were for
- Food & beverage$1,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $324 |
| AbbVie | 13 | $240 |
| AstraZeneca | 10 | $155 |
| Lilly USA, LLC | 7 | $104 |
| Biohaven Pharmaceuticals, Inc. | 2 | $98 |
| GSK | 5 | $84 |
| Amgen | 4 | $78 |
| Pfizer | 4 | $74 |
| Astellas Pharma US Inc | 4 | $63 |
| Abbott | 3 | $60 |
| Dexcom, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$1,444 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 35 | $37,043 |
| OzempicSemaglutide | 25 | $31,430 |
| Atorvastatin Calcium | 105 | $1,442 |
| Losartan Potassium | 92 | $1,235 |
| Levothyroxine Sodium | 70 | $1,047 |
| Lisinopril | 104 | $840 |
| Pantoprazole Sodium | 45 | $781 |
| Sertraline Hcl | 57 | $684 |
| Duloxetine Hcl | 16 | $627 |
| Amlodipine Besylate | 89 | $620 |
| Omeprazole | 71 | $581 |
| Montelukast Sodium | 55 | $573 |
| Metformin Hcl | 38 | $553 |
| Buspirone Hcl | 24 | $517 |
| Gabapentin | 32 | $477 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $104 | $37,04335 claims |
| Novo NordiskOzempic | $324 | $31,43025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,657 family providers in Michigan.
Other family in Commerce Township
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.